Explore

Reuters Reuters
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development

By Maggie Fick LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely lucrative weight-loss drug market, said on Tuesday it is partnering with OpenAI to deploy artificial intelligence across its business, from drug discovery to manufacturing
Trendline Trendline
Novo Nordisk Partners with OpenAI to Accelerate AI-Driven Drug Discovery

Novo Nordisk Partners with OpenAI to Accelerate AI-Driven Drug Discovery

Novo Nordisk Partners with OpenAI to Accelerate AI-Driven Drug Discovery
Trendline Trendline
Pharmaceutical Industry Faces Economic Challenges Due to High Drug Development Failure Rates

Pharmaceutical Industry Faces Economic Challenges Due to High Drug Development Failure Rates

Pharmaceutical Industry Faces Economic Challenges Due to High Drug Development Failure Rates
Trendline Trendline
AI's Role in Drug Discovery: Transforming Development Strategies for Success

AI's Role in Drug Discovery: Transforming Development Strategies for Success

AI's Role in Drug Discovery: Transforming Development Strategies for Success
Trendline Trendline
Pharmaphorum Report Highlights February 2026 Trends in Life Sciences

Pharmaphorum Report Highlights February 2026 Trends in Life Sciences

Pharmaphorum Report Highlights February 2026 Trends in Life Sciences
Trendline Trendline
Oracle's Stock Surges 11% Amid AI Developments and Market Rebound

Oracle's Stock Surges 11% Amid AI Developments and Market Rebound

Oracle's Stock Surges 11% Amid AI Developments and Market Rebound
Trendline Trendline
OpenAI CEO Sam Altman's Home Allegedly Targeted in Second Attack, Two Arrests Made

OpenAI CEO Sam Altman's Home Allegedly Targeted in Second Attack, Two Arrests Made

OpenAI CEO Sam Altman's Home Allegedly Targeted in Second Attack, Two Arrests Made
Trendline Trendline
AI in Healthcare: Progress in Drug Discovery but No FDA Approvals Yet

AI in Healthcare: Progress in Drug Discovery but No FDA Approvals Yet

AI in Healthcare: Progress in Drug Discovery but No FDA Approvals Yet
Trendline Trendline
Biopharma Industry Urged to Align on Data for Effective AI Integration

Biopharma Industry Urged to Align on Data for Effective AI Integration

Biopharma Industry Urged to Align on Data for Effective AI Integration
Trendline Trendline
Oracle Announces Major Workforce Reduction to Focus on AI Infrastructure

Oracle Announces Major Workforce Reduction to Focus on AI Infrastructure

Oracle Announces Major Workforce Reduction to Focus on AI Infrastructure
Trendline Trendline
Oracle Restructures Workforce and Capital to Boost AI Infrastructure

Oracle Restructures Workforce and Capital to Boost AI Infrastructure

Oracle Restructures Workforce and Capital to Boost AI Infrastructure
Trendline Trendline
OpenAI's Codex Demonstrates Autonomous Software Navigation in Adobe Lightroom

OpenAI's Codex Demonstrates Autonomous Software Navigation in Adobe Lightroom

OpenAI's Codex Demonstrates Autonomous Software Navigation in Adobe Lightroom